Passive transfer of local immunity to influenza virus infection by IgA antibody.
about
Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodiesCryotomography of budding influenza A virus reveals filaments with diverse morphologies that mostly do not bear a genome at their distal endChimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 virusesAdjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodiesDirect administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea.Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosageImmune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.Intranasal antibody prophylaxis for protection against viral disease.Homeostasis of the gut barrier and potential biomarkers.Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluidsRole of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infectionSpecific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.Role of interleukin-12 in primary influenza virus infectionCD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization.Oral microbial ecology and the role of salivary immunoglobulin ARobust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1Microbial-immune cross-talk and regulation of the immune system.MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infectionEvaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cellsCharacterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.Full inactivation of human influenza virus by high hydrostatic pressure preserves virus structure and membrane fusion while conferring protection to mice against infection.Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection.Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in miceIntracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin.Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenzaEnteric immunization of mice against influenza with recombinant vacciniaThe contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.Production of secretory immunoglobulin A by a single mammalian cellMonoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis
P2860
Q24306450-1CF5983F-7D62-4BD2-9131-3882C6704219Q27334559-7025FD91-2150-4E18-AA1D-A5CF520BCE3EQ28365124-1878B651-F378-41C8-8C2C-526CEE970BF0Q30355516-17F27F95-5428-44AD-9E69-B174C96C32B8Q30374373-554C5C90-B182-4A5B-BC07-3375B5C9B77DQ30422513-F535F841-51CA-4859-B2A9-BFF380B62CF3Q30430275-5613FEC3-276F-4837-AC68-1EE7E51739E2Q32077043-0EBAFFAD-258D-401D-945D-0070F3BF741AQ33592225-954AA79A-3DAC-4AF5-BFA7-2D2A55CA9B29Q33595830-605CAD72-D7DE-4A30-988E-4E23FBDAF98EQ33597587-DB4317ED-B814-4D3D-9FA0-298F4F2F704DQ33683058-32FC64FC-22C2-4EAE-82B8-C23DC6ECE48EQ33715804-B1832EB2-A721-4242-B883-09A75A268D79Q33725110-AD4E2DBE-D842-4B42-A850-D046A627D240Q33763109-FA077344-791A-4AFF-B4C3-316791CD7889Q33769451-B1FE8F81-819F-488E-837C-B3BCBDFCAC7AQ33784078-40EE7E15-1593-439D-9C2C-AFECBE76913EQ33801890-155C417C-DD3F-40B8-9028-372B1F592C37Q33886927-CB0FCB72-30AA-44D7-83EE-2B00DFD630B9Q34003245-74B4B1DC-70C5-4F65-8275-395D3652056CQ34006839-27636312-6BF7-42BB-A7CA-4B951438149EQ34009973-8A6312FF-B037-423F-A33A-E6AA198D7B53Q34175747-FC15DA70-05CD-4257-9133-8CE35D15EC60Q34288647-B7BE4878-A8B3-45B3-849F-0FA2CA2106C9Q34416382-CB270296-1987-42D6-9AC5-D8900796C316Q34717658-EB32A0B3-C429-423E-84DD-8DB5B2EBA3D3Q34781840-10DD3AF4-C798-431F-9C6F-96431AE8D41BQ35055154-4D6CF7CF-250F-4754-AEFB-58E9E0F7774DQ35498094-A1B27A71-927F-448D-A938-3F2A74873B55Q35786912-4CFC14B8-1E85-4CB7-A3C9-A0FCF80AB538Q35823116-CA92A9C5-24CB-4A13-A03A-9F159556A5A7Q35833488-B7777DF9-0188-4B61-81DA-F8D9EEE33050Q35837146-82ED49CC-636E-4952-B1F8-BE24BD1D9A82Q35845659-F33E7A07-3597-423D-97DF-69CBF8BA4099Q35865606-A9FC74EA-F415-46F1-A568-DC89CDEFB0A6Q35868774-D54665A2-E7E0-4DFA-B7A8-A7F3E72D834AQ35900617-D983B48C-F1DA-40C9-B3D4-F898576A5CC9Q35943771-5C504E54-4BAB-4417-A9ED-B15C1214343FQ36184551-C5624E2A-0E41-4E66-A8D4-B08AA6355E31Q36365336-0359B796-192E-4986-A03A-B4D249EB5279
P2860
Passive transfer of local immunity to influenza virus infection by IgA antibody.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@en
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@nl
type
label
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@en
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@nl
prefLabel
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@en
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@nl
P1476
Passive transfer of local immunity to influenza virus infection by IgA antibody.
@en
P2093
Renegar KB
Small PA Jr
P304
P407
P577
1991-03-01T00:00:00Z